SEO URLwww.firestrike.ai/deals/azstarys-collegium-pharmaceutical-acquisition-2026

acquisitionAnnounced · Mar 19, 2026BiopharmaceuticalSource · CredibleArticle · Factual

AZSTARYS · Collegium Pharmaceutical

Collegium Pharmaceutical acquires AZSTARYS

David Najork · Founding Software Engineer

Announced Mar 19, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$650M

Target

AZSTARYS

Acquirer

Collegium Pharmaceutical

Full Acquisition

Status

Pending

Collegium Pharmaceutical agreed to acquire AZSTARYS. Reported deal value: $650M. Status: Pending. Sector: Biopharmaceutical. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-03-19. Figures and status may change as filings and press coverage update.

Collegium Pharmaceutical , Inc. has announced a definitive agreement to acquire AZSTARYS from Corium Therapeutics for $650 million in cash, with potential milestone payments up to $ 13 5 million

Deal timeline

Announced

Mar 19, 2026 · nasdaq.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Biopharmaceutical with a reported deal value of $650M. Figures and status may change as sources update.

Sources: nasdaq.com · Primary article · FireStrike proprietary index